Clinical Trial Update: Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials of Forteo (teriparatide) for unexplained osteoporosis in premenopausal women have completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: Columbia University | Conditions: Menopause, Fracture | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-07-26